BioCentury
ARTICLE | Clinical News

Dotarem gadoterate meglumine regulatory update

February 18, 2013 8:00 AM UTC

FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval of Dotarem gadoterate meglumine from Guerbet to detect and visualize areas with disruption of the blood-brain barrier an...